These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2526212)

  • 41. Peptides as potential antinociceptive drugs.
    Silbert BS; Lipkowski AW; Carr DB; Szyfelbein SK; Osgood PF
    Prog Clin Biol Res; 1990; 328():485-8. PubMed ID: 2304963
    [No Abstract]   [Full Text] [Related]  

  • 42. Reinforcing effects of the enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Aug; 166(3):453-8. PubMed ID: 2806371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fentanyl and morphine discrimination in rats continuously infused with fentanyl.
    Emmett-Oglesby MW; Shippenberg TS; Herz A
    Behav Pharmacol; 1989; 1(1):3-11. PubMed ID: 11175382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies.
    Kudla L; Bugno R; Podlewska S; Szumiec L; Wiktorowska L; Bojarski AJ; Przewlocki R
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors.
    Kudla L; Przewlocki R
    Pharmacol Rep; 2021 Aug; 73(4):1033-1051. PubMed ID: 33835467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.
    Kudla L; Bugno R; Skupio U; Wiktorowska L; Solecki W; Wojtas A; Golembiowska K; Zádor F; Benyhe S; Buda S; Makuch W; Przewlocka B; Bojarski AJ; Przewlocki R
    Br J Pharmacol; 2019 Dec; 176(23):4434-4445. PubMed ID: 31347704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.
    Yaksh TL; Eddinger KA; Kokubu S; Wang Z; DiNardo A; Ramachandran R; Zhu Y; He Y; Weren F; Quang D; Malkmus SA; Lansu K; Kroeze WK; Eliceiri B; Steinauer JJ; Schiller PW; Gmeiner P; Page LM; Hildebrand KR
    Anesthesiology; 2019 Jul; 131(1):132-147. PubMed ID: 31225809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitization.
    Feehan AK; Zadina JE
    J Neuroinflammation; 2019 May; 16(1):100. PubMed ID: 31109346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the guanine nucleotide binding protein, Gα
    Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
    Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
    Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
    Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
    Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
    J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
    Hruba L; Ginsburg BC; McMahon LR
    J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology.
    Lamb K; Tidgewell K; Simpson DS; Bohn LM; Prisinzano TE
    Drug Alcohol Depend; 2012 Mar; 121(3):181-8. PubMed ID: 22119134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.
    Raehal KM; Schmid CL; Groer CE; Bohn LM
    Pharmacol Rev; 2011 Dec; 63(4):1001-19. PubMed ID: 21873412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.
    Dang VC; Christie MJ
    Br J Pharmacol; 2012 Mar; 165(6):1704-1716. PubMed ID: 21564086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human.
    Morgan MM; Christie MJ
    Br J Pharmacol; 2011 Oct; 164(4):1322-34. PubMed ID: 21434879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse.
    Madia PA; Dighe SV; Sirohi S; Walker EA; Yoburn BC
    Psychopharmacology (Berl); 2009 Dec; 207(3):413-22. PubMed ID: 19816677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.
    Kumar P; Sunkaraneni S; Sirohi S; Dighe SV; Walker EA; Yoburn BC
    Eur J Pharmacol; 2008 Nov; 597(1-3):39-45. PubMed ID: 18789923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.
    Meyer PJ; Fossum EN; Ingram SL; Morgan MM
    Neuropharmacology; 2007 Jun; 52(8):1580-5. PubMed ID: 17445843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.